Retina Research Institute, LLC
This will be a prospective, randomized, controlled non-inferiority trial comparing the efficacy of Iheezo versus subconjunctival 2% lidocaine in reducing intravitreal injection pain scores up to 24 hours after injection.
The purpose of this study is to assess and compare patient pain and symptom levels up to 24 hours post-intravitreal injection when using Iheezo (Chloroprocaine HCl ophthalmic gel 3%) versus subconjunctival Lidocaine (2%) for pre-procedure anesthesia. Both medications are approved to be used for pre-procedure anesthesia. Approximately 80 subjects will participate in this study.
Inclusion Criteria: * At least 1 previous intravitreal injection in the last 180 days from screening. Exclusion Criteria: * History of more than 13 intravitreal injections.
Topical anesthetic for intravitreal injection
Procedural anesthetic for intravitreal injection
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.